Sun Pharmaceuticals | SUNP - Ebit

Sun Pharmaceuticals reported INR23.47B in EBIT for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebit Change
Aspen Pharmacare APN:SJ ZAR 3.72B 1.08B
Bharat Petroleum BPCL:IN INR 26.26B 27.72B
Cipla CIPLA:IN INR 11.35B 1.32B
Dr.Reddys Laboratories DRRD:IN INR 16.28B 360M
Jiangsu Hengrui Me. 600276:CH CNY 1.07B 234.47M
Reliance Infra RELI:IN INR 250.6B 35.66B
Sh Fosun Pharma 600196:CH CNY 658.65M 535.96M
Sun Pharmaceuticals SUNP:IN INR 23.47B 2.41B
UPL UPLL:IN INR 24.1B 2.5B